000			02199 a2200589 4500
005			20250513224208.0
264		0	_c20001130
008			200011s 0 0 eng d
022			_a0028-4793
024	7		_a10.1056/NEJM200011233432103 _2doi
040			_aNLM _beng _cNLM
100	1		_aBombardier, C
245	0	0	_aComparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. _h[electronic resource]
260			_bThe New England journal of medicine _c11 2000
300			_a1520-8, 2 p following 1528 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aArthritis, Rheumatoid _xdrug therapy
650	0	4	_aCardiovascular Diseases _xmortality
650	0	4	_aCyclooxygenase 2
650	0	4	_aCyclooxygenase 2 Inhibitors
650	0	4	_aCyclooxygenase Inhibitors _xtherapeutic use
650	0	4	_aDuodenal Obstruction _xchemically induced
650	0	4	_aFemale
650	0	4	_aGastric Outlet Obstruction _xchemically induced
650	0	4	_aGastrointestinal Diseases _xchemically induced
650	0	4	_aGastrointestinal Hemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aIsoenzymes _xantagonists & inhibitors
650	0	4	_aLactones _xadverse effects
650	0	4	_aMale
650	0	4	_aMembrane Proteins
650	0	4	_aMiddle Aged
650	0	4	_aNaproxen _xadverse effects
650	0	4	_aPeptic Ulcer _xchemically induced
650	0	4	_aProportional Hazards Models
650	0	4	_aProstaglandin-Endoperoxide Synthases
650	0	4	_aSulfones
700	1		_aLaine, L
700	1		_aReicin, A
700	1		_aShapiro, D
700	1		_aBurgos-Vargas, R
700	1		_aDavis, B
700	1		_aDay, R
700	1		_aFerraz, M B
700	1		_aHawkey, C J
700	1		_aHochberg, M C
700	1		_aKvien, T K
700	1		_aSchnitzer, T J
773	0		_tThe New England journal of medicine _gvol. 343 _gno. 21 _gp. 1520-8, 2 p following 1528
856	4	0	_uhttps://doi.org/10.1056/NEJM200011233432103 _zAvailable from publisher's website
999			_c11029499 _d11029499